The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Postnatal Phencyclidine Administration Selectively Reduces Adult Cortical Parvalbumin-Containing Interneurons
Abstract
Transient postnatal NMDA receptor blockade by phencyclidine (PCP), ketamine, or MK-801 induces developmental neuroapoptosis and adult behavioral deficits, which resemble abnormal human behaviors typically present in schizophrenia. This study tested the hypothesis that PCP-induced developmental apoptosis causes a specific deficit of GABAergic interneurons containing parvalbumin (PV), calretinin (CR), or calbindin (CB). Young adult (PND56) rats that were given a single dose of PCP (10 mg/kg) on PND7 exhibited no densitometric change of either CR or CB neurons in any brain region studied, but demonstrated a selective deficit of PV-containing neurons in the superficial layers (II-IV) of the primary somatosensory (S1), motor (M), and retrosplenial cortices, but not in the striatum (CPu) or hippocampus. Further, CR and CB neurons, which were expressed at the time of PCP administration, showed no colocalization with cellular markers of apoptosis (terminal dUTP nick-end labeling (TUNEL) of broken DNA or cleaved caspase-3), indicating that CR- and CB-containing neurons were protected from the toxic effect of PCP and survived into adulthood. This suggests that the deletion of PV neurons occurred during development, but cleaved caspase-3 showed no colocalization with BrdU, a specific marker of S-phase proliferation. These data suggest that the loss of PV-containing neurons was not due to an effect of PCP on proliferating neurons, but rather an effect on post-mitotic neurons. The developmental dependence and neuronal specificity of this effect of PCP provides further evidence that this model may be valuable in exploring the pathophysiology of schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, PVI are especially vulnerable to NMDAR hypofunction during development (Abekawa et al., 2007; Powell et al., 2012; Wang et al., 2008; Wang et al., 2013).”
From Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology? (2016) · cites this paper as Wang et al., 2008
In the citing paper
“early postnatal PCP reduces the number of adult PVþ neurons in the PFC.58”
From Adolescent Onset of Cortical Disinhibition in Schizophrenia: Insights From Animal Models (2011) · cites this paper as [58]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Meta-analysis of regional brain volumes in schizophrenia
Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., David, A. S., Murray, R. M., & Bullmore, E. T. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.16 · Cited by 1,662
Ethanol Inhibits NMDA-Activated Ion Current in Hippocampal Neurons
Lovinger, D. M., White, G., & Weight, F. F. (1989) · Science · doi:10.1126/science.2467382 · Cited by 1,448
Ethanol-Induced Apoptotic Neurodegeneration and Fetal Alcohol Syndrome
Ikonomidou, C., Bittigau, P., Ishimaru, M. J., Wozniak, D. F., Koch, C. A., Genz, K., Price, M. T., Stefovska, V. G., Hörster, F., Tenkova, T., et al. (2000) · Science · doi:10.1126/science.287.5455.1056 · Cited by 1,382
Calcium-binding proteins in the nervous system
Baimbridge, K. G., Celio, M. R., & ROGERS, J. H. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90081-i · Cited by 1,329
Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., John Suckling, A., Phillips, L., Yung, A. R., Bullmore, E. T., Brewer, W. J., Soulsby, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12323-9 · Cited by 1,309
GABAergic Interneurons Implications for Understanding Schizophrenia and Bipolar Disorder
Benes, F. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00225-1 · Cited by 1,082
New stereological methods for counting neurons
West, M. J. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90112-o · Cited by 940
Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938
Study of a New Schizophrenomimetic Drug—Sernyl
LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921
The reduced neuropil hypothesis: a circuit based model of schizophrenia
Selemon, L. D., & Goldman-Rakic, P. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00281-9 · Cited by 909
Benes, F. M. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810350036005 · Cited by 891
Prenatal developmental disturbances in the limbic allocortex in schizophrenics
Jakob, H., & Beckmann, H. (1986) · Journal of Neural Transmission · doi:10.1007/bf01249090 · Cited by 875
Brain abnormality in schizophrenia
Lawrie, S. M., & Abukmeil, S. S. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.172.2.110 · Cited by 845
Steen, R. G., Mull, C., Mcclure, R., Hamer, R. M., & Lieberman, J. A. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.6.510 · Cited by 832
Thompson, P. M., Vidal, C., Giedd, J. N., Gochman, P., Blumenthal, J., Nicolson, R., Toga, A. W., & Rapoport, J. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201243998 · Cited by 812
Hippocampal Volume Reduction in Schizophrenia as Assessed by Magnetic Resonance Imaging
Nelson, M. D., Saykin, A. J., Flashman, L. A., & Riordan, H. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.5.433 · Cited by 756
The cell cycle of the pseudostratified ventricular epithelium of the embryonic murine cerebral wall
Takahashi, T., Nowakowski, R. S., & Caviness, V. S. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-09-06046.1995 · Cited by 673
Taupin, P. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.08.002 · Cited by 645
Miller, M. W., & Nowakowski, R. S. (1988) · Brain Research · doi:10.1016/0006-8993(88)90055-8 · Cited by 613
A Stereotaxic Atlas of the Developing Rat Brain
Sherwood, N. M., & Timiras, P. S. (1970) · Medical Entomology and Zoology · Cited by 588
N‐Methyl‐D‐Aspartate Receptors and Ethanol: Inhibition of Calcium Flux and Cyclic GMP Production
Hoffman, P. L., Rabe, C. S., Moses, F. E., & Tabakoff, B. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07280.x · Cited by 566
Pakkenberg, B. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810230039007 · Cited by 565
Gur, R. E., Cowell, P., Turetsky, B. I., Gallacher, F., Cannon, T., Bilker, W., & Gur, R. C. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.145 · Cited by 540
Some Cytoarchitectural Abnormalities of the Entorhinal Cortex in Schizophrenia
Arnold, S. E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310043008 · Cited by 523
Condé, F., Lund, J. S., Jacobowitz, D. M., Baimbridge, K. G., & Lewis, D. A. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903410109 · Cited by 500
Young, C., Jevtović‐Todorović, V., Qin, Y.-Q., Tenkova, T. I., Wang, H., Labruyere, J., & Olney, J. W. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706301 · Cited by 470
A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
Benes, F. M., Kwok, E. W., Vincent, S. L., & Todtenkopf, M. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00138-3 · Cited by 470
Zhang, Z. J., & Reynolds, G. P. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00188-8 · Cited by 460
Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics
BEASLEY, C., & REYNOLDS, G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00122-3 · Cited by 426
Neuroimaging studies of the hippocampus in schizophrenia
Heckers, S. (2001) · Hippocampus · doi:10.1002/hipo.1068 · Cited by 420
Hof, P. R., Glezer, I. I., Condé, F., Flagg, R. A., Rubin, M. B., Nimchinsky, E. A., & Weisenhorn, D. M. V. (1999) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(98)00065-9 · Cited by 411
A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia
Woo, T.-U. W., Whitehead, R. E., Melchitzky, D. S., & Lewis, D. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5341 · Cited by 410
Schizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder?
Powell, C. M., & Miyakawa, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.008 · Cited by 381
Calcium buffering properties of calbindin D28k and parvalbumin in rat sensory neurones.
Chard, P. S., Bleakman, D., Christakos, S., Fullmer, C. S., & Miller, R. J. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019950 · Cited by 347
Atlas Of The Developing Rat Brain
Paxinos, G., & Fritchle, A. L. R. (1991) · Medical Entomology and Zoology · Cited by 345
Benes, F. M., Vincent, S. L., & Todtenkopf, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01084-8 · Cited by 327
Pathophysiologically based treatment interventions in schizophrenia
Lewis, D. A., & González‐Burgos, G. (2006) · Nature Medicine · doi:10.1038/nm1478 · Cited by 324
Wozniak, D. F., Hartman, R. E., Boyle, M. A., Vogt, S. K., Brooks, A., Tenkova, T. I., YOUNG, C., Olney, J. W., & Muglia, L. J. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.006 · Cited by 302
Scallet, A. C. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh224 · Cited by 298
Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia
Young, K. A., Manaye, K. F., Liang, C., Hicks, P. B., & German, D. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00826-x · Cited by 286
Ontogeny of the calcium binding protein parvalbumin in the rat nervous system
Solbach, S., & Celio, M. R. (1991) · Anatomy and Embryology · doi:10.1007/bf00942742 · Cited by 262
GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia
Lewis, D. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00042-9 · Cited by 257
Subnucleus-specific loss of neurons in medial thalamus of schizophrenics
Popken, G. J., Bunney, W. E., Potkin, S. G., & Jones, E. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150243397 · Cited by 253
Rujescu, D., Bender, A., Keck, M. E., Hartmann, A. M., Ohl, F., Ræder, H., Giegling, I., Genius, J., McCarley, R. W., Möller, H., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.029 · Cited by 241
Ethanol-Induced Caspase-3 Activation in the in Vivo Developing Mouse Brain
Olney, J. W., Tenkova, T. I., Dikranian, K. T., Muglia, L. J., Jermakowicz, W. J., D’Sa-Eipper, C., & Roth, K. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0475 · Cited by 240
Postmortem Assessment of Thalamic Nuclear Volumes in Subjects With Schizophrenia
Byne, W. M., Buchsbaum, M. S., Mattiace, L. A., Hazlett, E. A., Kemether, E. M., Elhakem, S. L., Purohit, D. P., Haroutunian, V. H., & Jones, L. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.59 · Cited by 239
Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration
Fredriksson, A., Archer, T., Alm, H., Gordh, T., & Eriksson, P. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.12.026 · Cited by 238
Takahashi, T., Nowakowski, R. S., & Caviness, V. S. (1992) · Journal of Neurocytology · doi:10.1007/bf01194977 · Cited by 237
Cochran, S. M., Kennedy, M., McKerchar, C. E., Steward, L. J., Pratt, J. A., & MORRIS, B. J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300031 · Cited by 236
Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis
Davidson, L. L., & Heinrichs, R. W. (2003) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00118-x · Cited by 232
Structural brain imaging in schizophrenia: a selective review
Pearlson, G. D., & Marsh, L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00071-2 · Cited by 218
Cotter, D., Landau, S., Beasley, C. L., Stevenson, R. N., Chana, G., MacMillan, L., & Everall, I. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01243-4 · Cited by 211
Meta-analysis of thalamic size in schizophrenia
Konick, L. C., & Friedman, L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00974-4 · Cited by 210
Pakkenberg, B. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90065-l · Cited by 207
Eldridge, S. R., Tilbury, L. F., Goldsworthy, T. L., & Butterworth, B. E. (1990) · Carcinogenesis · doi:10.1093/carcin/11.12.2245 · Cited by 206
Keilhoff, G., Becker, A., Grecksch, G., Wolf, G. L., & Bernstein, H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.039 · Cited by 206
Abdul-Monim, Z., Neill, J. C., & Reynolds, G. P. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107067097 · Cited by 206
Dynamics of cell proliferation in the adult dentate gyrus of two inbred strains of mice
Hayes, N. L., & Nowakowski, R. S. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00324-8 · Cited by 201
Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons
Woo, T., Miller, J. L., & Lewis, D. A. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.7.1013 · Cited by 191
Lewis, D. A., Cruz, D. A., Melchitzky, D. S., & Pierri, J. N. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1411 · Cited by 190
Dános, P. (1998) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(97)00071-1 · Cited by 189
Hippocampal Neuron Number in Schizophrenia
Heckers, S. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810350042006 · Cited by 188
DAVISS, S. R., & Lewis, D. A. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02720-3 · Cited by 187
Gritti, I., Manns, I. D., Mainville, L., & Jones, B. E. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10505 · Cited by 178
Alc�ntara, S., Ferrer, I., & Soriano, E. (1993) · Anatomy and Embryology · doi:10.1007/bf00191452 · Cited by 174
Long‐term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism
Harris, L. W., Sharp, T., Gartlon, J. E., Jones, D. N. C., & Harrison, P. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02902.x · Cited by 162
Packard, D. S., Menzies, R. A., & Skalko, R. G. (1973) · Differentiation · doi:10.1111/j.1432-0436.1973.tb00137.x · Cited by 154
Reynolds, G. P., Abdul-Monim, Z., Neill, J. C., & Zhang, Z. (2004) · Neurotoxicity Research · doi:10.1007/bf03033297 · Cited by 150
Volumes of association thalamic nuclei in schizophrenia: a postmortem study
Dános, P., Baumann, B., Krämer, A., Bernstein, H.-G., Stauch, R., Krell, D., Falkai, P., & Bogerts, B. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00307-9 · Cited by 148
Hayes, N. L., & Nowakowski, R. S. (2000) · Developmental Neuroscience · doi:10.1159/000017426 · Cited by 147
Gogtay, N., Sporn, A. L., CLASEN, L. S., Nugent, T. F., GREENSTEIN, D. K., Nicolson, R., Giedd, J. N., Lenane, M., Gochman, P., Evans, A. C., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.17 · Cited by 146
Egerton, A., Reid, L., McKerchar, C. E., MORRIS, B. J., & Pratt, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2109-y · Cited by 139
GABAergic neuronal subtypes in the human frontal cortex — development and deficits in schizophrenia
Reynolds, G. P., & Beasley, C. L. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00113-2 · Cited by 138
Reynolds, G. P., Zhang, Z. J., & Beasley, C. L. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00526-3 · Cited by 138
Falkai, P., Schneider-Axmann, T., & Honer, W. G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00250-4 · Cited by 122
Abekawa, T., Ito, K., Nakagawa, S., & Koyama, T. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0729-8 · Cited by 118
Komitova, M., Perfilieva, E., Mattsson, B., Eriksson, P. S., & Johansson, B. B. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200207000-00010 · Cited by 113
Neuronal calcium-binding proteins and schizophrenia
Eyles, D. W., McGrath, J. J., & Reynolds, G. P. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00299-7 · Cited by 113
Estimated Neuronal Populations and Volumes of the Hippocampus and Its Subfields in Schizophrenia
Walker, M. A., Highley, J. R., Esiri, M. M., McDonald, B., Roberts, H. C., Evans, S. P., & Crow, T. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.821 · Cited by 107
The fate of 5-bromodeoxyuridine, 5-bromodeoxycytidine, and 5-iododeoxycytidine in man.
Kriss, J. P., Maruyama, Y., Tung, L. A., Bond, S. B., & Révész, L. (1963) · PubMed · Cited by 98
Cochran, S. M., Fujimura, M., MORRIS, B. J., & Pratt, J. A. (2002) · Synapse · doi:10.1002/syn.10126 · Cited by 85
Takadera, T., Matsuda, I., & Ohyashiki, T. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730548.x · Cited by 81
S�nchez, M. P., Frassoni, C., Álvarez-Bolado, G., Spreafico, R., & Fair�n, A. (1992) · Journal of Neurocytology · doi:10.1007/bf01181587 · Cited by 81
Reynolds, G. P., Beasley, C. L., & Zhang, Z. J. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200072 · Cited by 79
Cell cycle kinetics in the embryonic mouse corpus striatum
Bhide, P. G. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961028)374:4 · Cited by 73
Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD
Fredriksson, A., & Archer, T. (2004) · Neurotoxicity Research · doi:10.1007/bf03033280 · Cited by 72
Altered organization of cortical interneurons in rats exposed to ethanol during neonatal life
Granato, A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.11.024 · Cited by 62
A modified cupric-silver technique for the impregnation of degenrating neurons and their processes
Carlsen, J., & de Olmos, J. S. (1981) · Brain Research · doi:10.1016/0006-8993(81)90571-0 · Cited by 58
Yoon, W. J., Won, S. J., Ryu, B. R., & Gwag, B. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01724.x · Cited by 52
Wang, C. Z., & Johnson, K. M. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20559 · Cited by 51
Self-citationMa, L., Swalla, B. J., Zhou, J., Dobias, S. L., Bell, J. R., Chen, J., Maxson, R. E., & Jeffery, W. R. (1996) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199603)205:3 · Cited by 50
The Role of Caspase-3 Activation in Phencyclidine-Induced Neuronal Death in Postnatal Rats
Wang, C. Z., & Johnson, K. M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301202 · Cited by 48
Self-citationLocalization and Mechanism of Thymidine Transport in the Central Nervous System
Spector, R., & Berlinger, W. G. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb07968.x · Cited by 48
Development of the Telencephalon: Neural Stem Cells, Neurogenesis, and Neuronal Migration
Bayer, S. A., & Altman, J. (2004) · Elsevier eBooks · doi:10.1016/b978-012547638-6/50003-1 · Cited by 46
Sadikot, A. F., Burhan, A. M., Bélanger, M.-C., & Sasseville, R. (1998) · Developmental Brain Research · doi:10.1016/s0165-3806(97)00148-x · Cited by 46
Reduction in Intracellular Calcium Levels Induces Injury in Developing Neurons
Turner, C. P., Pulciani, D., & Rivkees, S. A. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8027 · Cited by 44
Thomas, S. A., & Segal, M. B. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00930-4 · Cited by 39
Hyperactivity following postnatal NMDA antagonist treatment: Reversal by D-amphetamine
Fredriksson, A., & Archer, T. (2003) · Neurotoxicity Research · doi:10.1007/bf03033165 · Cited by 35
Kovalenko, S., Bergmann, A. K., Schneider-Axmann, T., Ováry, I., Majtényi, K., Havas, L., Honer, W. G., Bogerts, B., & Falkai, P. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45124 · Cited by 35
Widespread Neonatal Brain Damage following Calcium Channel Blockade
Turner, C. P., Miller, R., Smith, C. M., Brown, L., Blackstone, K., Dunham, S. R., Strehlow, R., Manfredi, M., Slocum, P. C., Iverson, K., et al. (2006) · Developmental Neuroscience · doi:10.1159/000095221 · Cited by 30
Defective transport of thymidine by cultured cells resistant to 5‐bromodeoxyuridine
Lynch, T. P., Cass, C. E., & Paterson, A. R. P. (1977) · Journal of Supramolecular Structure · doi:10.1002/jss.400060309 · Cited by 20
Wheeler, D. G., Dixon, G., & Harper, C. G. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.041 · Cited by 12
Thomas, S., Davson, H., & Mb, S. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004003 · Cited by 9
Cited by
Sorted by citations
Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585
Neill, J. C., Barnes, S. A., Cook, S., Grayson, B., Idris, N. F., McLean, S. L., Snigdha, S., Rajagopal, L., & Harte, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.004 · Cited by 541
GABAergic interneuron origin of schizophrenia pathophysiology
Nakazawa, K., Zsiros, V., Jiang, Z., Nakao, K., Kolata, S., Zhang, S., & Belforte, J. E. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.022 · Cited by 498
Kantrowitz, J. T., & Javitt, D. C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.006 · Cited by 414
Steullet, P., Cabungcal, J.-H., Coyle, J., Didriksen, M., Gill, K., Grace, A. A., Hensch, T. K., LaMantia, A.-S., Lindemann, L., Maynard, T. M., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.47 · Cited by 360
Metadata
- Authors
- Wang, C. Z., Yang, S. F., Xia, Y., & Johnson, K. M.
- Affiliations
- The University of Texas Medical Branch at Galveston (US)
- Corresponding author
- Wang, Cheng Z
- Johnson, Kenneth M
- ORCID
- Xia, Yan
- Venue
- Neuropsychopharmacology
- Published
- 2007-12-05
- Volume
- 33
- Issue
- 10
- Pages
- 2442-2455
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2026782090
- Cited by
- 161
- References
- 110
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 9 · 2018: 6 · 2017: 9 · 2016: 6 · 2015: 13 · 2014: 13 · 2013: 11 · 2012: 7
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services
- University of Texas Medical Branch
- National Institutes of Health (5r01mh063871-04)
- National Institute of Mental Health (MH63871)
- National Institute on Drug Abuse (DA 02073, R01DA002073)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Anesthesia and Neurotoxicity Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- phencyclidine, NMDA receptor blockade, parvalbumin interneurons, calretinin, calbindin, GABAergic interneurons, schizophrenia model, postnatal drug exposure, caspase-3, TUNEL, somatosensory cortex, motor cortex, retrosplenial cortex
- MeSH terms
- Animals, Animals, Newborn, Bromodeoxyuridine, Cell Count, Cell Survival, Cerebral Cortex, Disease Models, Animal, Female, Interneurons, Male, Parvalbumins, Phencyclidine, Schizophrenia, Time, Rats, Sprague-Dawley, Apoptosis, Excitatory Amino Acid Antagonists, Cell Proliferation, Rats, Caspase 3, Calbindins, S100 Calcium Binding Protein G, Calbindin 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review